期刊文献+

HIV合并HBV/HCV感染患者外周血T细胞亚群的变迁 被引量:3

The changes of peripheral blood T lymphocyte subset in the patients of HIV concurrent infection with HBV/HCV
下载PDF
导出
摘要 目的了解HIV合并HBV、HCV感染患者外周血T细胞亚群的变化特征,探讨HIV合并HBV和HCV感染后患者的免疫功能。方法采用三色流式细胞学检测技术,对26例HIV合并HBV和HCV感染患者(合并感染组)、35例单纯HIV感染患者(单纯感染组)和194例健康人群(健康对照组)外周血总T细胞、T4细胞、T8细胞含量进行测定并计算T4/T8比值。结果单纯感染组患者外周血总T细胞、T4细胞、T8细胞的百分含量和T4/T8比值分别为66.42±4.11、27.74±2.34、47.72±3.86和0.74±0.19,合并感染组分别为54.76±3.42、22.31±1.87、58.23±4.62和0.33±0.12,健康对照组值分别为69.98±5.79、35.25±5.16、25.08±4.34和1.45±0.28单纯感染组患者T4细胞和T4/T8比值明显低于健康对照组(P<0.05,P<0.01),T8细胞较对照组明显升高(P<0.05);合并感染组总T细胞、T4细胞和T4/T8比值明显低于健康对照组和单纯感染组(P<0.05,P<0.01),T8细胞较健康对照组和单纯感染组明显升高(P<0.05,P<0.01)。结论 HIV感染患者合并HBV和HCV感染将进一步加重体内免疫功能的紊乱;检测外周血T细胞亚群有利于HIV、HBV和HCV多重感染患者的鉴别诊断、病情监测以及预后判断,是一项十分有效的客观依据。 Objective To Analyze of the change character of peripheral blood T lymphocyte subset in the patients of HIV concurrent infection with HBV/HCV,and investigate the immune function of these patients.Methods Three color Flow cytometry was used to determine the peripheral blood total T cell,CD4+T cell,CD8+T cell and calculate CD4+T/CD8+T in 26 patients of HIV concurrent infection with HBV/HCV(concurrent infection group),35 patients with HIV only(simple infection group) and 194 health people(control group).Results The peripheral blood total T cell,CD4+T cell,CD8+T cell and CD4+T/CD8+T in simple infection group were 66.42±4.11,27.74±2.34,47.72±3.86 and 0.74±0.19,or concurrent infection group were 54.76±3.42,22.31±1.87,58.23±4.62 and 0.33±0.12;and control group were 69.98±5.79,35.25±5.16,25.08±4.34 and 1.45±0.28.Significantly higher percentage of CD8+T lymphocyte,lower of CD4+T lymphocyte and CD4+/CD8+ ratio in simple infection group were found,comparing to those in controls(P0.05 or P0.01).It was also demonstrate that in the group of concurrent infection,the percentage of total T lymphocyte,CD4+T lymphocyte and CD4+/CD8+ were lower and CD8+T lymphocyte was higher than those in simple infection group and control group(P0.05 or P0.01).Conclusion Concurrent infection with HBV and HCV in patient of HIV infection will aggravate immune disorder;Detection of peripheral blood T lymphocyte subset can be used to differential diagnosis,patients' condition motion and prognosis judgment in patients of HIV/HBV/HCV multiple infection.
出处 《国际检验医学杂志》 CAS 2011年第20期2313-2314,2316,共3页 International Journal of Laboratory Medicine
关键词 HIV 肝炎病毒 乙型 肝炎病毒 丙型 T淋巴细胞亚群 流式细胞术 HIV hepatitis B virus hepatitis C virus T lymphocyte subset flow cytometry
  • 相关文献

参考文献5

  • 1Cooksley H,Chokshi S,Maayan Y,et al. Hepatitis B virus e anti gen loss during adefovir dipivoxil therapy is associated with en hanced virus-specific CD4^+ T-cell reactivity [J]. Antimicrob A gents Chemother, 2008,52 ( 1 ) : 312-320.
  • 2Rehermann B,Chang KM, Mc Hutchinson J,et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients[J]. J Virol, 1996,70(10) :7092-7102.
  • 3Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with Hemophilia[J]. J Aequir Immune Defic Syndr,2001,26(5) :466-472.
  • 4Greub G, Ledergerber B,Battegay M,et al. Clinical progression,survival, and immune recovery during antiretrovival therapy in pa- tients with HIV-1 and hepatitis C virus eoinfeetion., the Swiss HIV cohort studv[J]. Laneed,2000,356i9244):1800-1805.
  • 5李太生,邱志峰,王爱霞,盛瑞媛.HIV感染和AIDS患者T淋巴细胞免疫病理改变的研究[J].中华医学杂志,2002,82(20):1391-1395. 被引量:21

二级参考文献12

  • 1Ullum H, Lepri AC, Victor J, et al. Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death: evidence from a cohort of 347 HIV-infected individuals. AIDS,1997, 11: 1479-1485.
  • 2June CH, Bluestone JA, Nadler LM, et al. The B7 and CD28 receptor families. Immunol Today, 1994, 15:321-331.
  • 3Brinchmann JE, Dobloug JH, Heger BH, et al. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J Infect Dis, 1994,169:730-738.
  • 4Funaro A, Spagnoli GC, Ausiello CM, et al. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol, 1990, 15: 2390- 2396.
  • 5Levacher M, Hulstaert F, Tallet S, et al. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol, 1992, 90: 376-382.
  • 6Giorgi JV, Liu Z, Hultin LE, et al. Elevated levels of CD38+CD8+T cells in HIV infection add to the prognostic value of low CD+ T cells levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr, 1993, 6:904-912.
  • 7Brinchmann JE. Differential responses of T cell subsets: possible role in the immunopathogenesis of AIDS. AIDS, 2000,14:1689-1700.
  • 8Autran B, Carcelain G,Li TS ,et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science, 1997, 277:112-116.
  • 91993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep, 1992,41(RR-17): 1-19.
  • 10Lang W, Perkins H, Anderson RE, et al. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr, 1989, 2: 63-69.

共引文献20

同被引文献11

  • 1Zaw SKK,Tun STT,Thida A,et al. Prevalence of hepati- tis C and B virus among patients infected with HIV.. a cross sectional analysis of a large HIV care programme in Myanmar [J]. Tropical doctor,2013,43(3)..113-115.
  • 2Konopnicki D,Mocroft A,De Wit S,et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort [J]. Aids, 2005,19(6) : 593-601.
  • 3Pol S. Management of HBV in immunocompromised pa tients [J]. Liver Int,2013,33(sl) :182 187.
  • 4Zhang X, Xing H, Feng X, et al. Hepatitis B virus (HBV)- specific T-cell responses to recombinant HBV core protein in patients with normal liver {unction and cinfected with chro- nic HBV and human immunodeficiency virus 1 (HIV1) [J]. Virol J,2013,10(1) ..232.
  • 5Collazos J,Cart6n J, Asensi V. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes [J]. HIV medicine,2011,12(5) ..308 315.
  • 6Prescher JA,Contag CH. Guided by the light: visualizing biomolecular processes in living animals with biolumines- cence [J]. Curr Opin Chem Biol,2010,14(1) ..80-89.
  • 7赵稳,姚细安,唐漾波,占晗琳.HIV感染者合并HBV及HCV感染情况分析[J].广东医学,2010,31(1):79-81. 被引量:23
  • 8陈超,游晶,杨微波,李俊敏.HIV/AIDS合并乙型肝炎病毒和(或)丙型肝炎病毒感染的研究进展[J].中国全科医学,2012,15(9):955-958. 被引量:10
  • 9孙洪清,肖宏,杨菲,李菊花,林文,陈良.HCV RNA水平对HCV/HIV合并感染自然进程的影响[J].医学研究杂志,2014,43(4):91-95. 被引量:5
  • 10吴丽娟,靳昌忠,白石,梁勇,吴南屏.合并病毒性肝炎HIV感染患儿接受高效抗逆转录酶病毒治疗后肝功能变化[J].浙江大学学报(医学版),2014,43(2):180-186. 被引量:6

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部